Results 111 to 120 of about 147,251 (203)

Case Report: A de novo NLRP3 variant resulting in autoinflammatory disease in a Chinese newborn. [PDF]

Front Immunol, 2023
Xie M, Wan J, Zheng X, Zou X, Chen W, Zhang K, Yuan H, Zhang Z, Zeng H.   +8 more
europepmc   +1 more source

Autoinflammatory disease: clinical perspectives and therapeutic strategies. [PDF]

Inflamm Regen, 2022
Kawakami A, Endo Y, Koga T, Yoshiura KI, Migita K.   +4 more
europepmc   +1 more source

Correction: Autoinflammatory disease: clinical perspectives and therapeutic strategies. [PDF]

Inflamm Regen, 2022
Kawakami A, Endo Y, Koga T, Yoshiura KI, Migita K.   +4 more
europepmc   +1 more source

VEXAS syndrome: an adult-onset monogenic autoinflammatory disease with many unanswered questions. [PDF]

Reumatologia, 2023
Hernández-Rodríguez J, Nieścieruk J, Maślińska M.   +2 more
europepmc   +1 more source

A unique presentation of NLRP3-associated autoinflammatory disease: case report. [PDF]

BMC Rheumatol, 2022
Ducharme-Bénard S, Roberge G, Chapdelaine H.   +2 more
europepmc   +1 more source

Systemic Autoinflammatory Disease and Genetic Testing. [PDF]

Rheumatol Immunol Res, 2021
Yao Q.
europepmc   +1 more source

IL-1 and autoinflammatory disease: biology, pathogenesis and therapeutic targeting. [PDF]

Nat Rev Rheumatol, 2022
Broderick L, Hoffman HM.
europepmc   +1 more source

Hearing Loss as the Main Clinical Presentation in NLRP3-Associated Autoinflammatory Disease. [PDF]

Front Immunol, 2022
Oziębło D, Leja ML, Jeznach A, Orzechowska M, Skirecki T, Więsik-Szewczyk E, Furmanek M, Bałdyga N, Skarżyński H, Ołdak M.   +9 more
europepmc   +1 more source

Before calling it FMF: MEFV variants of uncertain significance in autoinflammatory disease. [PDF]

Rheumatology (Oxford)
Cam V, Cingoz E, Ercan Emreol H, Unal D, Bayindir Y, Aliyev E, Erkan MO, Banak ON, Dara Kar HD, Basaran O, Bilginer Y, Sag E, Ozen S.   +12 more
europepmc   +1 more source

PAMI Syndrome: Two Cases of an Autoinflammatory Disease with an ALPS-Like Phenotype. [PDF]

J Clin Immunol, 2022
Cox F, Bigley V, Irvine A, Leahy R, Conlon N.   +4 more
europepmc   +1 more source